Sinistro Anna, Almerighi Cristiana, Ciaprini Chiara, Natoli Silvia, Sussarello Emanuele, Di Fino Sara, Calò-Carducci Francesca, Rocchi Giovanni, Bergamini Alberto
Department of Public Health and Cellular Biology, Intensive Care Unit, University of Rome Tor Vergata, Rome, Italy.
Clin Vaccine Immunol. 2008 Dec;15(12):1851-8. doi: 10.1128/CVI.00184-08. Epub 2008 Oct 22.
It has been suggested that a defective adaptive immune response contributes to septic immunosuppression. Here, the response of monocytes to CD40 ligand (CD40L) for patients with sepsis due to infection with gram-negative organisms has been analyzed. Compared to cells from controls, monocytes from septic patients showed significantly reduced production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-12 and were unable to acquire high levels of CD80 and CD86 molecules. These alterations were observed at the onset of sepsis and persisted at day 7. However, the ability of monocytes to respond to CD40L stimulation was partially but significantly restored in cells from patients who recovered from sepsis. In addition, costimulation of autologous CD4+ T lymphocytes by CD40L-activated monocytes from septic patients failed to induce cell proliferation and gamma interferon production. Finally, the ability of CD40L to rescue monocytes from apoptosis was severely impaired. We conclude that downregulation of the CD40L response may be an appropriate model for the monocyte alteration observed during septic immunosuppression and may help in the development of novel therapeutic strategies.
有人提出,适应性免疫反应缺陷会导致脓毒症免疫抑制。在此,我们分析了革兰氏阴性菌感染所致脓毒症患者单核细胞对CD40配体(CD40L)的反应。与对照组细胞相比,脓毒症患者的单核细胞肿瘤坏死因子α、白细胞介素-1β(IL-1β)和IL-12的产生显著减少,且无法获得高水平的CD80和CD86分子。这些改变在脓毒症发作时即被观察到,并持续至第7天。然而,脓毒症康复患者细胞中单核细胞对CD40L刺激的反应能力部分但显著恢复。此外,脓毒症患者经CD40L激活的单核细胞对自体CD4 + T淋巴细胞的共刺激未能诱导细胞增殖和γ干扰素产生。最后,CD40L挽救单核细胞免于凋亡的能力严重受损。我们得出结论,CD40L反应的下调可能是脓毒症免疫抑制期间观察到的单核细胞改变的合适模型,并可能有助于开发新的治疗策略。